Cargando…

Does route of administration affect the outcome of TNF antagonist therapy?

The tumor necrosis factor (TNF) antagonists are parenterally administered biologic response modifiers indicated for the management of rheumatoid arthritis. Although infliximab, etanercept, and adalimumab are all members of this class, they differ in route of administration and dosing regimen. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartzman, Sergio, Morgan, G James
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833461/
https://www.ncbi.nlm.nih.gov/pubmed/15228617
http://dx.doi.org/10.1186/ar996